F. Chedevergne

634 total citations
18 papers, 263 citations indexed

About

F. Chedevergne is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Immunology and Allergy. According to data from OpenAlex, F. Chedevergne has authored 18 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 3 papers in Immunology and Allergy. Recurrent topics in F. Chedevergne's work include Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (4 papers) and Child Nutrition and Feeding Issues (2 papers). F. Chedevergne is often cited by papers focused on Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (4 papers) and Child Nutrition and Feeding Issues (2 papers). F. Chedevergne collaborates with scholars based in France, Australia and Italy. F. Chedevergne's co-authors include Isabelle Sermet‐Gaudelus, Muriel Le Bourgeois, E. Lawson-Body, J.-C. Souberbielle, G. Lenoir, Jean Charles Ruiz, Thao Nguyen‐Khoa, Elena K. Schneider‐Futschik, Thomas Flament and Alexandre Hinzpeter and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Vaccine.

In The Last Decade

F. Chedevergne

18 papers receiving 257 citations

Peers

F. Chedevergne
J McGaw United Kingdom
Ann Scott United Kingdom
M Roussey France
J McGaw United Kingdom
F. Chedevergne
Citations per year, relative to F. Chedevergne F. Chedevergne (= 1×) peers J McGaw

Countries citing papers authored by F. Chedevergne

Since Specialization
Citations

This map shows the geographic impact of F. Chedevergne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Chedevergne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Chedevergne more than expected).

Fields of papers citing papers by F. Chedevergne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Chedevergne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Chedevergne. The network helps show where F. Chedevergne may publish in the future.

Co-authorship network of co-authors of F. Chedevergne

This figure shows the co-authorship network connecting the top 25 collaborators of F. Chedevergne. A scholar is included among the top collaborators of F. Chedevergne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Chedevergne. F. Chedevergne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bardin, Emmanuelle, Elodie Lamy, Bingqing Zhou, et al.. (2025). Short-term modification of breathprint by Elexacaftor/Tezacaftor/Ivacaftor in a paediatric cohort. Journal of Cystic Fibrosis. 24(3). 606–612. 1 indexed citations
2.
Bardin, Emmanuelle, Elodie Lamy, Bingqing Zhou, et al.. (2023). CFTR modulators modify exhaled breath of children with cystic fibrosis within a week.. PA3377–PA3377. 1 indexed citations
3.
Ciciriello, Fabiana, Tiphaine Bihouée, Christophe Marguet, et al.. (2022). Profiling the response to lumacaftor‐ivacaftor in children with cystic between fibrosis and new insight from a French‐Italian real‐life cohort. Pediatric Pulmonology. 57(12). 2992–2999. 3 indexed citations
4.
Nguyen‐Khoa, Thao, Mairead Kelly, Vincent Jung, et al.. (2022). Proteomic Profiling of Sweat in Patients with Cystic Fibrosis Provides New Insights into Epidermal Homoeostasis. SHILAP Revista de lepidopterología. 3(1). e161–e161. 4 indexed citations
5.
Drummond, David, Laureline Berteloot, Elena K. Schneider‐Futschik, et al.. (2021). Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR. Journal of Cystic Fibrosis. 21(2). 212–219. 27 indexed citations
6.
Chedevergne, F. & Isabelle Sermet‐Gaudelus. (2019). Prevention of osteoporosis in cystic fibrosis. Current Opinion in Pulmonary Medicine. 25(6). 660–665. 6 indexed citations
7.
Schneider‐Futschik, Elena K., Thao Nguyen‐Khoa, Emmanuelle Girodon, et al.. (2018). Predictive factors for lumacaftor/ivacaftor clinical response. Journal of Cystic Fibrosis. 18(3). 368–374. 54 indexed citations
8.
Dusser, Perrine, R. Freund, Gérard Maruani, et al.. (2016). Bioelectrical impedance in young patients with cystic fibrosis: Validation of a specific equation and clinical relevance. Journal of Cystic Fibrosis. 15(6). 825–833. 24 indexed citations
9.
Masson, Ana Paula, Odile Launay, Bertrand Delaisi, et al.. (2015). Vaccine coverage in CF children: A French multicenter study. Journal of Cystic Fibrosis. 14(5). 615–620. 12 indexed citations
10.
Ferroni, Agnès, et al.. (2015). Persistent Bordetella bronchiseptica infection in a child with cystic fibrosis: Relationship to bacterial phenotype. Journal of Cystic Fibrosis. 14(5). E13–E15. 8 indexed citations
11.
Launay, Odile, Pierre‐Yves Boëlle, Anne Krivine, et al.. (2014). Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis. Vaccine. 32(35). 4515–4521. 8 indexed citations
12.
Sermet‐Gaudelus, Isabelle, J.-C. Souberbielle, Jean Charles Ruiz, et al.. (2007). Low Bone Mineral Density in Young Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 175(9). 951–957. 68 indexed citations
13.
Sermet‐Gaudelus, Isabelle, et al.. (2006). [Anti Pseudomonas aeruginosa antibiotic therapy in cystic fibrosis (exclusion of macrolides)].. PubMed. 13 Suppl 1. S30–43. 1 indexed citations
14.
Paty, E., F. Chedevergne, P. Scheinmann, J.‐M. Wal, & Hervé Bernard. (2003). Allergie au lait de chèvre et de brebis sans allergie associée au lait de vache. Revue Française d Allergologie et d Immunologie Clinique. 43(7). 455–462. 7 indexed citations
15.
Ponvert, C., F. Chedevergne, Muriel Le Bourgeois, et al.. (2001). Diagnostic des réactions dˈhypersensibilité non immédiate aux bêtalactamines chez lˈenfant par les tests cutanés à lecture semi-retardée et retardée et par les tests de réintroduction. Revue Française d Allergologie et d Immunologie Clinique. 41(6). 544–554. 7 indexed citations
16.
Chedevergne, F., et al.. (2000). Cytokine transcripts in pediatric tuberculosis: a study with bronchoalveolar cells. Tubercle and Lung Disease. 80(6). 249–258. 7 indexed citations
17.
Chedevergne, F.. (2000). The role of inflammation in childhood asthma. Archives of Disease in Childhood. 82(90002). 6ii–9. 21 indexed citations
18.
Clainche, Laurence Le, et al.. (1999). Indications du « non traitementdes bronchiolites aiguës. Revue Française d Allergologie et d Immunologie Clinique. 39(1). 31–36. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026